CTI BioPharma Reports Second Quarter 2021 Financial Results
CTI BioPharma Reports Second Quarter 2021 Financial Results – NDA for Pacritinib for the Treatment of Myelofibrosis Patients with Severe Thrombocytopenia Under Priority Review by FDA with PDUFA Target Action Date of November 30, 2021 more...
Quantum Successfully Completes Debt Refinancing
Quantum Successfully Completes Debt Refinancing New Senior Secured Term Loan Reduces Annual Interest Cash Payments by $4 Million and Provides Significant Covenant and Operating Flexibility PR Newswire SAN JOSE, Calif. , Aug. 5, 2021 /PRNewswire/ — Quantum more...
Digimarc Reports Second Quarter 2021 Financial Results
Digimarc Reports Second Quarter 2021 Financial Results PR Newswire BEAVERTON, Ore. , Aug. 5, 2021 /PRNewswire/ — Digimarc Corporation (NASDAQ: DMRC) reported financial results for the second quarter ended June 30, 2021 . Second Quarter more...
Assertio Reports Second Quarter 2021 Financial Results
Reported Net Product Sales of $24.8 Million Raises Full Year Net Product Sales Guidance Range Narrows Previous Non-GAAP Adjusted EBITDA Guidance Range LAKE FOREST, Ill., Aug. 05, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” more...
iCAD Reports Financial Results for the Quarter Ended June 30, 2021
Conference Call Today at 4:30 PM ET NASHUA, N.H., Aug. 05, 2021 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its financial and more...
Eiger BioPharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
Eiger BioPharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update – HDV Platform Strategy Rapidly Advancing – Phase 3 HDV D-LIVR (Lonafarnib) >90% Enrolled; On-Track for Full Enrollment in 2021 – Phase 3 more...
Issuer Direct Reports Second Quarter 2021 Results
Record Total Revenue Led by Communications Revenue Increasing 16% to $3.5 million or 61% of Total Revenue, Net Income Increased 43% and EBITDA Increased 21% to $1.6 million or 29% of Revenue RALEIGH, NC / more...
electroCore Announces Second Quarter 2021 Financial Results
Second quarter 2021 net sales of $1.3 million, increased 69% over second quarter 2020 and 5% sequentially. Company to host a conference call and webcast today, August 5, 2021 at 4:30 pm ET ROCKAWAY, NJ, more...
Entasis Therapeutics to Report Second Quarter 2021 Results and Host Conference Call August 12, 2021
WALTHAM, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that management will report second more...
CymaBay Therapeutics to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021
NEWARK, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it more...